Diving physiopathology: the end of certainties? Food for thought.


Journal

Minerva anestesiologica
ISSN: 1827-1596
Titre abrégé: Minerva Anestesiol
Pays: Italy
ID NLM: 0375272

Informations de publication

Date de publication:
Oct 2019
Historique:
pubmed: 27 6 2019
medline: 22 7 2020
entrez: 27 6 2019
Statut: ppublish

Résumé

Our understanding of decompression physiopathology has slowly improved during this last decade and some uncertainties have disappeared. A better understanding of anatomy and functional aspects of patent foramen ovale (PFO) have slowly resulted in a more liberal approach toward the medical fitness to dive for those bearing a PFO. Circulating vascular gas emboli (VGE) are considered the key actors in development of decompression sickness and can be considered as markers of decompression stress indicating induction of pathophysiological processes not necessarily leading to occurrence of disease symptoms. During the last decade, it has appeared possible to influence post-dive VGE by a so-called "preconditioning" as a pre-dive denitrogenation, exercise or some pharmacological agents. In the text we have deeply examined all the scientific evidence about this complicated but challenging theme. Finally, the role of the "normobaric oxygen paradox" has been clarified and it is not surprising that it could be involved in neuroprotection and cardioprotection. However, the best level of inspired oxygen and the exact time frame to achieve optimal effect is still not known. The aim of this paper was to reflect upon the most actual uncertainties and distil out of them a coherent, balanced advice towards the researchers involved in gas-bubbles-related pathologies.

Identifiants

pubmed: 31238641
pii: S0375-9393.19.13618-8
doi: 10.23736/S0375-9393.19.13618-8
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1129-1137

Auteurs

Costantino Balestra (C)

Laboratory of Environmental and Occupational (Integrative) Physiology, Haute Ecole Bruxelles-Brabant, Auderghem, Brussels, Belgium.
Division of Research, Divers Alert Network Europe, Gharghur, Malta.

Peter Germonpré (P)

Laboratory of Environmental and Occupational (Integrative) Physiology, Haute Ecole Bruxelles-Brabant, Auderghem, Brussels, Belgium.
Division of Research, Divers Alert Network Europe, Gharghur, Malta.
Center for Hyperbaric Oxygen Therapy, Military Hospital of Brussels, Brussels, Belgium.

Monica Rocco (M)

Unit of Intensive Care, Department of Surgical and Medical Science and Translational Medicine, Sapienza University, Rome, Italy - monica.rocco@uniroma1.it.

Gianni Biancofiore (G)

Unit of Anesthesia and Intensive Care, University of Pisa, Pisa, Italy.

Jacek Kot (J)

National Center of Hyperbaric Medicine in Gdynia, Medical University of Gdansk, Gdansk, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH